As we described previously, CD8α+DCs are critical for cross-presentation of tumor and viral antigens (32, 118, 119) because of their well-specialized cross-presentation capacity and their superior ability to prime antitumor CTL responses (32, 119–121) without enhancing GVHD (8, 122). This evidence concerns the gene CD8A and neoplasm.